---
$id: https://graph.org.ai/products/commodity/51343705
$type: Product
source: UNSPSC
code: "51343705"
title: "Rilpivirine hydrochloride"
class: "51343700"
classTitle: "Antiviral ketones and morpholines and nitriles and pyridazines"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rilpivirine hydrochloride

**UNSPSC Code**: 51343705
**Class**: [Antiviral ketones and morpholines and nitriles and pyridazines](Antiviral ketones and morpholines and nitriles and pyridazines.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 212WAX8KDD. European Medicines Agency schedules Rilpivirine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31460. Rilpivirine hydrochloride generally arises in the molecular formula C22H18N6.CLH. The term 'rilpivirine hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule rilpivirine hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, RILPIVIRINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1CC(CC(C1NC2CCNC(N2)NC3CCC(CC3)C#N)C)/C=C/C#N.CL.

